valsartan has been researched along with Syndrome in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Li, D; Liu, Q; Xie, Y; Yan, J | 1 |
Rickenbacher, P | 1 |
Hasenfuss, G | 1 |
Millar, AB; Thickett, DR | 1 |
1 review(s) available for valsartan and Syndrome
Article | Year |
---|---|
[Heart failure with "mid-range" ejection fraction: a new clinical entity?]
Topics: Aged; Aminobutyrates; Benzimidazoles; Biomarkers; Biphenyl Compounds; Comorbidity; Coronary Disease; Drug Combinations; Drug Therapy, Combination; Evidence-Based Medicine; Heart Failure; Humans; Natriuretic Peptides; Perindopril; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Spironolactone; Stroke Volume; Survival Rate; Syndrome; Tetrazoles; Valsartan | 2018 |
1 trial(s) available for valsartan and Syndrome
Article | Year |
---|---|
[AT(1) blocker for post-infarct therapy. VALIANT Study].
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Survival Analysis; Syndrome; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
2 other study(ies) available for valsartan and Syndrome
Article | Year |
---|---|
Effect of Yiqi Huayu Pinggan Zishen Formula Combined with Valsartan in the Treatment of Hypertension and Its Effect on MMP-9, Ang II, and MCP-1.
Topics: Angiotensin II; Antihypertensive Agents; Chemokine CCL2; Drugs, Chinese Herbal; Humans; Hypertension; Matrix Metalloproteinase 9; Syndrome; Valsartan | 2022 |
Drug-induced antisynthetase syndrome.
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Anti-Inflammatory Agents; Arthritis; Autoantibodies; Autoimmune Diseases; Cytoskeleton; Humans; Male; Prednisolone; Pulmonary Fibrosis; Raynaud Disease; Skin Diseases; Syndrome; Tetrazoles; Valine; Valsartan | 1997 |